Abstract

Drugs of abuse represent a growing public health crisis. Accumulating evidence indicates that gabapentin (GBP), a prescription drug, is prone to misuse, abuse, withdrawal, and dependence. Commonly, drugs of abuse modulate the dopaminergic system to induce addiction. In this study, we used the conditioned place preference (CPP) model to investigate the involvement of the dopamine 1 (D1) receptor on the reward and reinforcement behavior of GBP. Under a CPP paradigm, male BALB/c mice were intraperitoneally injected either saline or 100, 200, or 300 mg/kg of GBP and confined to the injection-paired chamber for 30 min. In the pre-conditioning phase, mice were conditioned for 3 days, and baseline data were collected. In the conditioning phase, mice were given once-daily alternating injections of either GBP or saline for 8 days and subsequently assessed in a post-conditioning test. Injections of 300 mg/kg of GBP significantly increased the time spent in the drug-paired chamber compared to the saline-paired chamber. However, lower doses of GBP (100 and 200 mg/kg) showed no effect. Pre-treatment with SKF-83566, a D1 receptor antagonist, attenuated GBP-induced CPP. Thus, for the first time, we show that GBP can induce CPP through a dopaminergic-dependent mechanism.

Highlights

  • Drugs of abuse represent a growing public health crisis

  • We showed that blocking dopamine 1 (D1) receptor activity could prevent GBP-induced conditioned place preference (CPP)

  • The number of gabapentinoid misuse, abuse, dependence, and overdose incidences reported by the Food And Drug Administration Adverse Events Reporting System (FAERS) between 2012 and 2016 is alarming and requires immediate attention from the regulatory ­authorities[2]

Read more

Summary

Introduction

Drugs of abuse represent a growing public health crisis. Accumulating evidence indicates that gabapentin (GBP), a prescription drug, is prone to misuse, abuse, withdrawal, and dependence. We used the conditioned place preference (CPP) model to investigate the involvement of the dopamine 1 (D1) receptor on the reward and reinforcement behavior of GBP. Studies in animal models have found that the reinforcing effects of different drugs of abuse such as methamphetamine, cocaine, and heroin are associated with high levels of dopamine in the mesocorticolimbic ­system[16]. The release of dopamine in the mesocorticolimbic system is thought to be related to the activity of drugs of abuse in the ventral tegmental area, which projects into the nucleus accumbens and the medial prefrontal cortex, among other brain r­ egions[17] Repeated exposure to these drugs produces a behavioral sensitization state that promotes a­ ddiction[18]. D2 receptors have been suggested to be involved more in mediating motor ­functions[28,29]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call